M.M. Dillon

M.M. Dillon & Co., founded in 2004 and based in Greenwich, Connecticut, provides investment banking services with a focus on the middle market. The firm specializes in mergers and acquisitions, capital raising, private placements, capital restructuring, public equity offerings, and transaction advisory. M.M. Dillon & Co. aims to deliver personalized, high-quality expertise to growth enterprises, including public companies and privately owned businesses, particularly in the healthcare, technology, media, and telecommunications sectors. Unlike larger investment banks that prioritize high-value clients and transactions, M.M. Dillon & Co. is dedicated to serving clients that require tailored guidance in navigating complex financial situations.

George Bickerstaff

Co-Founder and Managing Director

1 past transactions

Akonni Biosystems

Series D in 2017
Akonni Biosystems is a biotechnology company that develops and manufactures, genetic testing devices. Its devices are designed for complex infectious and human health diseases like Methicillin-resistant Staphylococcus aureus (MRSA), multi-drug-resistant tuberculosis (MDR-TB), and influenza sub-typing with oseltamivir-resistance detection. It was founded in 2003 and headquartered in Maryland, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.